Compare Stocks

3 / 10
Try these comparisons:

Stock Comparison

NDAQ vs ICE vs CME

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
NDAQ
Nasdaq, Inc.

Financial - Data & Stock Exchanges

Financial ServicesNASDAQ • US
Market Cap$50.71B
5Y Perf.+125.9%
ICE
Intercontinental Exchange, Inc.

Financial - Data & Stock Exchanges

Financial ServicesNYSE • US
Market Cap$86.89B
5Y Perf.+57.7%
CME
CME Group Inc.

Financial - Data & Stock Exchanges

Financial ServicesNASDAQ • US
Market Cap$104.61B
5Y Perf.+57.9%

NDAQ vs ICE vs CME — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
NDAQ logoNDAQ
ICE logoICE
CME logoCME
IndustryFinancial - Data & Stock ExchangesFinancial - Data & Stock ExchangesFinancial - Data & Stock Exchanges
Market Cap$50.71B$86.89B$104.61B
Revenue (TTM)$8.22B$12.64B$6.52B
Net Income (TTM)$1.91B$3.30B$4.24B
Gross Margin47.9%61.9%86.1%
Operating Margin28.4%38.7%64.9%
Forward P/E22.7x19.1x23.6x
Total Debt$9.93B$20.28B$3.76B
Cash & Equiv.$814M$837M$4.42B

NDAQ vs ICE vs CMELong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

NDAQ
ICE
CME
StockMay 20May 26Return
Nasdaq, Inc. (NDAQ)100225.9+125.9%
Intercontinental Ex… (ICE)100157.7+57.7%
CME Group Inc. (CME)100157.9+57.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: NDAQ vs ICE vs CME

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: NDAQ leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Intercontinental Exchange, Inc. is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
NDAQ
Nasdaq, Inc.
The Banking Pick

NDAQ carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 11.1%, EPS growth 60.1%
  • 351.9% 10Y total return vs CME's 291.2%
  • 11.1% NII/revenue growth vs CME's 6.4%
Best for: growth exposure and long-term compounding
ICE
Intercontinental Exchange, Inc.
The Banking Pick

ICE is the clearest fit if your priority is income & stability and sleep-well-at-night.

  • Dividend streak 14 yrs, beta 0.33, yield 1.3%
  • Lower volatility, beta 0.33, Low D/E 69.9%, current ratio 1.02x
  • Beta 0.33, yield 1.3%, current ratio 1.02x
Best for: income & stability and sleep-well-at-night
CME
CME Group Inc.
The Banking Pick

CME is the clearest fit if your priority is valuation efficiency.

  • PEG 1.72 vs ICE's 2.15
  • 3.8% yield, 6-year raise streak, vs ICE's 1.3%
Best for: valuation efficiency
See the full category breakdown
CategoryWinnerWhy
GrowthNDAQ logoNDAQ11.1% NII/revenue growth vs CME's 6.4%
ValueICE logoICELower P/E (19.1x vs 22.7x)
Quality / MarginsNDAQ logoNDAQEfficiency ratio 0.2% vs ICE's 0.2% (lower = leaner)
Stability / SafetyICE logoICEBeta 0.33 vs NDAQ's 0.78, lower leverage
DividendsCME logoCME3.8% yield, 6-year raise streak, vs ICE's 1.3%
Momentum (1Y)NDAQ logoNDAQ+15.6% vs ICE's -11.3%
Efficiency (ROA)NDAQ logoNDAQEfficiency ratio 0.2% vs ICE's 0.2%

NDAQ vs ICE vs CME — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

NDAQNasdaq, Inc.
FY 2025
Market Services
51.4%$4.2B
Capital Access Platforms
26.1%$2.1B
Market Technology
22.6%$1.9B
ICEIntercontinental Exchange, Inc.
FY 2025
Fixed Income And Data Services Segment
51.1%$1.4B
Exchanges Segment
38.8%$1.0B
Mortgage Technology Segment
10.1%$269M
CMECME Group Inc.
FY 2025
clearing and transaction fees
81.0%$5.3B
MarketData
12.3%$803M
OtherRevenue
6.7%$436M

NDAQ vs ICE vs CME — Financial Metrics

Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCMELAGGINGNDAQ

Income & Cash Flow (Last 12 Months)

CME leads this category, winning 4 of 5 comparable metrics.

ICE is the larger business by revenue, generating $12.6B annually — 1.9x CME's $6.5B. CME is the more profitable business, keeping 62.0% of every revenue dollar as net income compared to NDAQ's 21.8%.

MetricNDAQ logoNDAQNasdaq, Inc.ICE logoICEIntercontinental …CME logoCMECME Group Inc.
RevenueTrailing 12 months$8.2B$12.6B$6.5B
EBITDAEarnings before interest/tax$3.1B$6.5B$4.7B
Net IncomeAfter-tax profit$1.9B$3.3B$4.2B
Free Cash FlowCash after capex$2.0B$4.3B$4.4B
Gross MarginGross profit ÷ Revenue+47.9%+61.9%+86.1%
Operating MarginEBIT ÷ Revenue+28.4%+38.7%+64.9%
Net MarginNet income ÷ Revenue+21.8%+26.1%+62.0%
FCF MarginFCF ÷ Revenue+24.2%+33.9%+64.3%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year+33.8%+23.1%+21.4%
CME leads this category, winning 4 of 5 comparable metrics.

Valuation Metrics

ICE leads this category, winning 4 of 7 comparable metrics.

At 25.8x trailing earnings, CME trades at a 10% valuation discount to NDAQ's 28.9x P/E. Adjusting for growth (PEG ratio), CME offers better value at 1.88x vs ICE's 2.99x — a lower PEG means you pay less per unit of expected earnings growth.

MetricNDAQ logoNDAQNasdaq, Inc.ICE logoICEIntercontinental …CME logoCMECME Group Inc.
Market CapShares × price$50.7B$86.9B$104.6B
Enterprise ValueMkt cap + debt − cash$59.8B$106.3B$103.9B
Trailing P/EPrice ÷ TTM EPS28.87x26.59x25.84x
Forward P/EPrice ÷ next-FY EPS est.22.70x19.14x23.61x
PEG RatioP/E ÷ EPS growth rate2.70x2.99x1.88x
EV / EBITDAEnterprise value multiple20.18x16.47x23.08x
Price / SalesMarket cap ÷ Revenue6.17x6.88x16.04x
Price / BookPrice ÷ Book value/share4.20x3.02x3.62x
Price / FCFMarket cap ÷ FCF25.49x20.26x24.95x
ICE leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

CME leads this category, winning 5 of 9 comparable metrics.

NDAQ delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $12 for ICE. CME carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to NDAQ's 0.81x. On the Piotroski fundamental quality scale (0–9), NDAQ scores 9/9 vs CME's 5/9, reflecting strong financial health.

MetricNDAQ logoNDAQNasdaq, Inc.ICE logoICEIntercontinental …CME logoCMECME Group Inc.
ROE (TTM)Return on equity+15.9%+11.6%+15.3%
ROA (TTM)Return on assets+6.4%+2.3%+2.2%
ROICReturn on invested capital+8.1%+7.5%+10.2%
ROCEReturn on capital employed+10.2%+9.5%+3.6%
Piotroski ScoreFundamental quality 0–9995
Debt / EquityFinancial leverage0.81x0.70x0.13x
Net DebtTotal debt minus cash$9.1B$19.4B-$666M
Cash & Equiv.Liquid assets$814M$837M$4.4B
Total DebtShort + long-term debt$9.9B$20.3B$3.8B
Interest CoverageEBIT ÷ Interest expense14.11x6.53x41.55x
CME leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — NDAQ and CME each lead in 3 of 6 comparable metrics.

A $10,000 investment in NDAQ five years ago would be worth $17,172 today (with dividends reinvested), compared to $14,243 for ICE. Over the past 12 months, NDAQ leads with a +15.6% total return vs ICE's -11.3%. The 3-year compound annual growth rate (CAGR) favors CME at 19.9% vs ICE's 14.0% — a key indicator of consistent wealth creation.

MetricNDAQ logoNDAQNasdaq, Inc.ICE logoICEIntercontinental …CME logoCMECME Group Inc.
YTD ReturnYear-to-date-7.4%-3.8%+9.7%
1-Year ReturnPast 12 months+15.6%-11.3%+5.9%
3-Year ReturnCumulative with dividends+67.7%+48.2%+72.2%
5-Year ReturnCumulative with dividends+71.7%+42.4%+64.1%
10-Year ReturnCumulative with dividends+351.9%+222.9%+291.2%
CAGR (3Y)Annualised 3-year return+18.8%+14.0%+19.9%
Evenly matched — NDAQ and CME each lead in 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — NDAQ and CME each lead in 1 of 2 comparable metrics.

CME is the less volatile stock with a -0.30 beta — it tends to amplify market swings less than NDAQ's 0.78 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NDAQ currently trades 87.6% from its 52-week high vs ICE's 81.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricNDAQ logoNDAQNasdaq, Inc.ICE logoICEIntercontinental …CME logoCMECME Group Inc.
Beta (5Y)Sensitivity to S&P 5000.78x0.33x-0.30x
52-Week HighHighest price in past year$101.79$189.35$329.16
52-Week LowLowest price in past year$77.09$143.17$257.17
% of 52W HighCurrent price vs 52-week peak+87.6%+81.0%+87.6%
RSI (14)Momentum oscillator 0–10052.042.041.7
Avg Volume (50D)Average daily shares traded3.3M3.1M2.2M
Evenly matched — NDAQ and CME each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — ICE and CME each lead in 1 of 2 comparable metrics.

Analyst consensus: NDAQ as "Buy", ICE as "Buy", CME as "Hold". Consensus price targets imply 28.5% upside for NDAQ (target: $115) vs 11.1% for CME (target: $320). For income investors, CME offers the higher dividend yield at 3.79% vs NDAQ's 1.17%.

MetricNDAQ logoNDAQNasdaq, Inc.ICE logoICEIntercontinental …CME logoCMECME Group Inc.
Analyst RatingConsensus buy/hold/sellBuyBuyHold
Price TargetConsensus 12-month target$114.60$195.71$320.25
# AnalystsCovering analysts363635
Dividend YieldAnnual dividend ÷ price+1.2%+1.3%+3.8%
Dividend StreakConsecutive years of raises13146
Dividend / ShareAnnual DPS$1.04$1.93$10.92
Buyback YieldShare repurchases ÷ mkt cap+1.2%+1.6%+0.3%
Evenly matched — ICE and CME each lead in 1 of 2 comparable metrics.
Key Takeaway

CME leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ICE leads in 1 (Valuation Metrics). 3 tied.

Best OverallCME Group Inc. (CME)Leads 2 of 6 categories
Loading custom metrics...

NDAQ vs ICE vs CME: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is NDAQ or ICE or CME a better buy right now?

For growth investors, Nasdaq, Inc.

(NDAQ) is the stronger pick with 11. 1% revenue growth year-over-year, versus 6. 4% for CME Group Inc. (CME). CME Group Inc. (CME) offers the better valuation at 25. 8x trailing P/E (23. 6x forward), making it the more compelling value choice. Analysts rate Nasdaq, Inc. (NDAQ) a "Buy" — based on 36 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — NDAQ or ICE or CME?

On trailing P/E, CME Group Inc.

(CME) is the cheapest at 25. 8x versus Nasdaq, Inc. at 28. 9x. On forward P/E, Intercontinental Exchange, Inc. is actually cheaper at 19. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: CME Group Inc. wins at 1. 72x versus Intercontinental Exchange, Inc. 's 2. 15x — a reasonable growth-adjusted valuation.

03

Which is the better long-term investment — NDAQ or ICE or CME?

Over the past 5 years, Nasdaq, Inc.

(NDAQ) delivered a total return of +71. 7%, compared to +42. 4% for Intercontinental Exchange, Inc. (ICE). Over 10 years, the gap is even starker: NDAQ returned +351. 9% versus ICE's +222. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — NDAQ or ICE or CME?

By beta (market sensitivity over 5 years), CME Group Inc.

(CME) is the lower-risk stock at -0. 30β versus Nasdaq, Inc. 's 0. 78β — meaning NDAQ is approximately -358% more volatile than CME relative to the S&P 500. On balance sheet safety, CME Group Inc. (CME) carries a lower debt/equity ratio of 13% versus 81% for Nasdaq, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — NDAQ or ICE or CME?

By revenue growth (latest reported year), Nasdaq, Inc.

(NDAQ) is pulling ahead at 11. 1% versus 6. 4% for CME Group Inc. (CME). On earnings-per-share growth, the picture is similar: Nasdaq, Inc. grew EPS 60. 1% year-over-year, compared to 15. 4% for CME Group Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — NDAQ or ICE or CME?

CME Group Inc.

(CME) is the more profitable company, earning 62. 0% net margin versus 21. 8% for Nasdaq, Inc. — meaning it keeps 62. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CME leads at 64. 9% versus 28. 4% for NDAQ. At the gross margin level — before operating expenses — CME leads at 86. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is NDAQ or ICE or CME more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, CME Group Inc. (CME) is the more undervalued stock at a PEG of 1. 72x versus Intercontinental Exchange, Inc. 's 2. 15x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Intercontinental Exchange, Inc. (ICE) trades at 19. 1x forward P/E versus 23. 6x for CME Group Inc. — 4. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NDAQ: 28. 5% to $114. 60.

08

Which pays a better dividend — NDAQ or ICE or CME?

All stocks in this comparison pay dividends.

CME Group Inc. (CME) offers the highest yield at 3. 8%, versus 1. 2% for Nasdaq, Inc. (NDAQ).

09

Is NDAQ or ICE or CME better for a retirement portfolio?

For long-horizon retirement investors, CME Group Inc.

(CME) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 30), 3. 8% yield, +291. 2% 10Y return). Both have compounded well over 10 years (CME: +291. 2%, NDAQ: +351. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between NDAQ and ICE and CME?

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: NDAQ is a mid-cap quality compounder stock; ICE is a mid-cap quality compounder stock; CME is a mid-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

NDAQ

Quality Mega-Cap Compounder

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 13%
Run This Screen
Stocks Like

ICE

Quality Mega-Cap Compounder

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 15%
Run This Screen
Stocks Like

CME

Dividend Mega-Cap Quality

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 37%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform NDAQ and ICE and CME on the metrics below

Revenue Growth>
%
(NDAQ: 11.1% · ICE: 7.5%)
Net Margin>
%
(NDAQ: 21.8% · ICE: 26.1%)
P/E Ratio<
x
(NDAQ: 28.9x · ICE: 26.6x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.